BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6647546)

  • 1. The analysis of the red cell unsaturated fatty acid test for multiple sclerosis using laser cytopherometry.
    Jones R; Preece AW; Luckman NP; Forrester JA
    Phys Med Biol; 1983 Oct; 28(10):1145-51. PubMed ID: 6647546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the erythrocyte-UFA (E-UFA) mobility test for the diagnosis of multiple sclerosis.
    Cuypers J; Reddemann H
    J Neurol Neurosurg Psychiatry; 1980 Nov; 43(11):995-8. PubMed ID: 7441283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red cell electrophoretic mobility test for early diagnosis of multiple sclerosis.
    Tamblyn CH; Swank RL; Seaman GV; Zukoski CF
    Neurol Res; 1980; 2(1):69-83. PubMed ID: 6114451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte-UFA (Eufa) mobility test for multiple sclerosis: implications for pathogenesis and handling of the disease.
    Field EJ; Joyce G; Smith BM
    J Neurol; 1977 Jan; 214(2):113-27. PubMed ID: 64595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the red blood cell cytopherometric test for the diagnosis of multiple sclerosis.
    Stoof JC; Vrijmoed-de Vries MC; Koetsier JC; Langevoort HL
    Acta Neurol Scand; 1977 Aug; 56(2):170-6. PubMed ID: 899719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simplified red-cell electrophoretic mobility test for multiple sclerosis.
    Seaman GV; Swank RL; Tamblyn CH; Zukoski CF
    Lancet; 1979 May; 1(8126):1138-9. PubMed ID: 86856
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of plasma for immediate diagnosis of multiple sclerosis (plasma-erythrocyte unsaturated fatty acid test): comparison with the erythrocyte-unsaturated fatty acid (E-UFA) test.
    Field EJ; Joyce G
    Neurol Res; 1986 Mar; 8(1):57-60. PubMed ID: 2871511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further observations with the erythrocyte-unsaturated fatty acid test. A contribution to the genetics of multiple sclerosis.
    Joyce G; Field EJ
    Eur Neurol; 1980; 19(4):266-72. PubMed ID: 7398689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sialic acid and fatty acid concentrations in lymphocytes, red blood cells and plasma from patients with multiple sclerosis.
    Cherayil GD
    J Neurol Sci; 1984 Jan; 63(1):1-10. PubMed ID: 6699649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The linoleic acid depression (LAD) test for multiple sclerosis using the macrophage electrophoretic mobility (MEM) test.
    Jenssen HL; Meyer-Rienecker HJ; Köhler H; Günther JK
    Acta Neurol Scand; 1976 Jan; 53(1):51-60. PubMed ID: 1251680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A laser Doppler cytopherometer for measurement of electrophoretic mobility of bioparticles.
    Preece AW; Luckman NP
    Phys Med Biol; 1981 Jan; 26(1):11-18. PubMed ID: 7017768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-UFA test in multiple sclerosis.
    Bisaccia G; Caputo D; Zibetti A
    Boll Ist Sieroter Milan; 1978 Jan; 56(6):583-8. PubMed ID: 629850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte electrophoretic mobility test for multiple sclerosis.
    Hawkins SA; Millar JH
    Lancet; 1979 Jan; 1(8108):165-6. PubMed ID: 84195
    [No Abstract]   [Full Text] [Related]  

  • 14. Linoleic-acid-dependent slowing of erythrocyte sedimentation in multiple sclerosis.
    Mayer M
    Prostaglandins Leukot Essent Fatty Acids; 1991 Dec; 44(4):257-8. PubMed ID: 1815242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prolonged ingestion of gamma-linolenate by MS patients.
    Field EJ; Joyce G
    Eur Neurol; 1978; 17(2):67-76. PubMed ID: 631143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential fatty acid and lipid profiles in plasma and erythrocytes in patients with multiple sclerosis.
    Cunnane SC; Ho SY; Dore-Duffy P; Ells KR; Horrobin DF
    Am J Clin Nutr; 1989 Oct; 50(4):801-6. PubMed ID: 2801584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific laboratory test for diagnosis of multiple sclerosis.
    Field EJ; Shenton BK; Joyce G
    Br Med J; 1974 Mar; 1(5905):412-4. PubMed ID: 4856264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring changes in the blood of patients with multiple sclerosis.
    Jones R; Capildeo R; Preece AW; Luckman NP; Clifford Rose F
    Prog Brain Res; 1983; 59():333-8. PubMed ID: 6665128
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of in vitro hyperthermia on fatty acids of red blood cells and plasma lipids from patients with multiple sclerosis.
    Cherayil GD
    J Neurol Sci; 1990 Feb; 95(2):141-51. PubMed ID: 2324765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma origin of red-cell-membrane changes in multiple sclerosis.
    Seaman GV; Swank RL; Tamblyn CH
    Lancet; 1980 Apr; 1(8174):938. PubMed ID: 6103296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.